AGN-242266 FXR Agonist

AGN-242266 FXR Agonist is a compound being investigated for non-alcoholic steatohepatitis.

Type of Molecule

Small Molecule

Target

Farnesoid X Receptor

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
Non-alcoholic Steatohepatitis (NASH) n/a
Phase 1